Roche Reports CHF 46.49 Billion in Sales for the First Nine Months of 2026

On 22 October, Roche reported group sales of CHF 46.493 billion for January–September 2026, up 6% at constant exchange rates, with third-quarter sales increasing 7% at constant exchange rates. Growth was supported by medicines and diagnostics, including demand for key pharmaceutical products; healthcare providers and medical researchers can explore clinical-data analysis and research computing, while HPC can support suitable data-intensive workloads. Contact HPC for a project-specific quotation.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.